EU may have 'relied a little bit too much on the free markets' for vaccines, top scientist says


The United States and the United Kingdom are outpacing the European Union when it comes to vaccinating citizens against COVID-19. The main reason why that's the case, The New York Times reports, appears to go all the way back to last year.
Early on, the U.S. and U.K. governments threw a lot more money at, and were much more involved in, vaccine development than the EU, which "shopped for vaccines like a customer," the Times writes. Brussels "assumed that simply contracting to acquire doses would be enough," Dr. Moncef Slaoui, who was hired by former President Donald Trump to oversee Operation Warp Speed's vaccine development, told the Times. "In fact," he added, "what was very important was to be a full, active partner in the development and manufacturing of the vaccine. And to do so very early."
Dr. Steven Van Gucht, the Belgium government's top virologist, seemed to agree, telling the Times he thinks European leaders "relied a little bit too much on the free markets. What you really need to do from the beginning is really make sure you produce the vaccines on your territory and that they're destined for your own population."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There is good news, though. The EU purchased enough doses to fully vaccinate its population three times over, and supply is expected to increase steadily in the next few weeks, leaving EU officials confident the bloc can hit the 70 percent vaccinated threshold by this summer. Read more at The New York Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The backlash against ChatGPT's Studio Ghibli filter
The Explainer The studio's charming style has become part of a nebulous social media trend
By Theara Coleman, The Week US Published
-
Why are student loan borrowers falling behind on payments?
Today's Big Question Delinquencies surge as the Trump administration upends the program
By Joel Mathis, The Week US Published
-
Not there yet: The frustrations of the pocket AI
Feature Apple rushes to roll out its ‘Apple Intelligence’ features but fails to deliver on promises
By The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published